These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 26894927)

  • 21. Genetic variants in the regulatory region of SLC10A1 are not associated with the risk of hepatitis B virus infection and clearance.
    Chen X; Wang Y; Chen X; Cheng K; Li J; Lou J; Ke J; Yang Y; Gong Y; Zhu Y; Wang L; Zhong R
    Infect Genet Evol; 2016 Oct; 44():495-500. PubMed ID: 27491457
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular evolution of hepatitis B vaccine escape variants in China, during 2000-2016.
    Wang J; Qiu J; Zhu Y; Zhou H; Yu L; Ding Y; Zhang L; Guo Z; Dong C
    Vaccine; 2017 Oct; 35(43):5808-5813. PubMed ID: 28939157
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relationship between programmed cell death-1 polymorphisms and clearance of hepatitis B virus.
    Ülger Y; Bayram S; Sandıkçı MÜ; Akgöllü E; Bekar A
    Int J Immunogenet; 2015 Jun; 42(3):133-9. PubMed ID: 25736598
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A double-dose hepatitis B vaccination schedule in travelers presenting for late consultation.
    Wong J; Payne M; Hollenberg S
    J Travel Med; 2014; 21(4):260-5. PubMed ID: 24796543
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Status of vaccination against hepatitis B among postgraduate students in medical higher education institutions in Guangzhou].
    Lin CS; Zhu JY; Mai L; Lee WH; Gao ZL
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2007 Jun; 21(2):114-6. PubMed ID: 17653308
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of the implementation of a vaccination strategy on hepatitis B virus infections in China over a 20-year period.
    Luo Z; Li L; Ruan B
    Int J Infect Dis; 2012 Feb; 16(2):e82-8. PubMed ID: 22178658
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence of non-responsiveness to an indigenous recombinant hepatitis B vaccine: a study among South Indian health care workers in a tertiary hospital.
    Thomas RJ; Fletcher GJ; Kirupakaran H; Chacko MP; Thenmozhi S; Eapen CE; Chandy G; Abraham P
    Indian J Med Microbiol; 2015 Feb; 33 Suppl():32-6. PubMed ID: 25657153
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genetic polymorphisms of CXCR5 and CXCL13 are associated with non-responsiveness to the hepatitis B vaccine.
    Duan Z; Chen X; Liang Z; Zeng Y; Zhu F; Long L; McCrae MA; Zhuang H; Shen T; Lu F
    Vaccine; 2014 Sep; 32(41):5316-22. PubMed ID: 25077417
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatitis B virus (HBV) reverse seroconversion (RS) can be prevented even in non-responders to hepatitis B vaccine after allogeneic stem cell transplantation: long-term analysis of intervention in RS with vaccine for patients with previous HBV infection.
    Takahata M; Hashino S; Onozawa M; Shigematsu A; Sugita J; Fujimoto K; Endo T; Kondo T; Tanaka J; Imamura M; Teshima T
    Transpl Infect Dis; 2014 Oct; 16(5):797-801. PubMed ID: 25154638
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of vaccine-acquired polyclonal anti-HBs antibodies on the prevention of HBV infection of non-vaccine genotypes.
    Kato M; Hamada-Tsutsumi S; Okuse C; Sakai A; Matsumoto N; Sato M; Sato T; Arito M; Omoteyama K; Suematsu N; Okamoto K; Kato T; Itoh F; Sumazaki R; Tanaka Y; Yotsuyanagi H; Kato T; Kurokawa MS
    J Gastroenterol; 2017 Sep; 52(9):1051-1063. PubMed ID: 28197802
    [TBL] [Abstract][Full Text] [Related]  

  • 31. SNP rs7770370 in HLA-DPB1 loci as a major genetic determinant of response to booster hepatitis B vaccination: results of a genome-wide association study.
    Wu TW; Chen CF; Lai SK; Lin HH; Chu CC; Wang LY
    J Gastroenterol Hepatol; 2015 May; 30(5):891-9. PubMed ID: 25389088
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatitis B immunity and response to booster vaccination in children with inflammatory bowel disease treated with infliximab.
    Moses J; Alkhouri N; Shannon A; Raig K; Lopez R; Danziger-Isakov L; Feldstein AE; Zein NN; Wyllie R; Carter-Kent C
    Am J Gastroenterol; 2012 Jan; 107(1):133-8. PubMed ID: 21876562
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HBV/HIV co-infection and APOBEC3G polymorphisms in a population from Burkina Faso.
    Compaore TR; Diarra B; Assih M; Obiri-Yeboah D; Soubeiga ST; Ouattara AK; Tchelougou D; Bisseye C; Bakouan DR; Compaore IP; Dembele A; Djigma WF; Simpore J
    BMC Infect Dis; 2016 Jul; 16():336. PubMed ID: 27449138
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of TNF-Alpha gene polymorphisms and susceptibility to hepatitis B virus infection in Egyptians.
    Talaat RM; Abdelkhalek MS; El-Maadawy EA; Abdel-Mageed WS; El-Shenawy SZ; Osman MA
    Hum Immunol; 2017 Nov; 78(11-12):739-746. PubMed ID: 29054398
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Polymorphisms in sodium taurocholate cotransporting polypeptide are not associated with hepatitis B virus clearance in Chinese Tibetans and Uygurs.
    Su Z; Li Y; Liao Y; Cai B; Chen J; Zhang J; Li L; Ying B; Tao C; Zhao M; Ba Z; Zhang Z; Wang L
    Infect Genet Evol; 2016 Jul; 41():128-134. PubMed ID: 27051045
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The evaluation of immune responses that occur after HBV infection and HBV vaccination in hemodialysis patients.
    Kara IH; Yilmaz ME; Suner A; Kadiroglu AK; Isikoglu B
    Vaccine; 2004 Sep; 22(29-30):3963-7. PubMed ID: 15364445
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of high dose and short interval HBV vaccination in individuals with chronic hepatitis C.
    Idilman R; De MN; Colantoni A; Nadir A; Van Thiel DH
    Am J Gastroenterol; 2002 Feb; 97(2):435-9. PubMed ID: 11866284
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficient haemodialysis improves the response to hepatitis B virus vaccination.
    Kovacic V; Sain M; Vukman V
    Intervirology; 2002; 45(3):172-6. PubMed ID: 12403922
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effectiveness of a bivalent Haemophilus influenzae type B-hepatitis B vaccine in preventing hepatitis B virus infection among children born to hepatitis B e antigen-positive carrier mothers.
    Doherty R; Garland S; Wright M; Bulotsky M; Liss C; Lakkis H; Nikas A; Straus W
    Pediatr Infect Dis J; 2009 Sep; 28(9):777-81. PubMed ID: 19636283
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Factors Affecting the Development of an Antibody Response to Hepatitis B Immunization in Children With Intestinal Failure: Before and After Small Bowel Transplantation (With and Without Liver Graft).
    Craggs HM; Jackson P; Gupte G; Hartley J; Abdel-Hady M; Morton R; Beath S; Hogg L
    JPEN J Parenter Enteral Nutr; 2017 Aug; 41(6):1030-1036. PubMed ID: 26962060
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.